Diuretika

  • A. Heidland
  • U. Bahner

Zusammenfassung

Als Diuretika bezeichnet man Substanzen, welche den Harnfluß zu steigern vermögen. Sie werden vor allem eingesetzt bei ödematösen oder salzretinierenden Krankheitszuständen, wie z. B. bei Herzinsuffizienz, nephrotischem Syndrom und Leberzirrhose. Aber auch bei der Behandlung einiger nichtödematöser Zustände, wie z. B. der essentiellen Hypertonie, spielen sie eine wichtige Rolle.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Ayus JC (1986) Diuretic-induced hyponatremia. Arch Intern Med. 146: 1295–1296PubMedCrossRefGoogle Scholar
  2. 2.
    Better OS, Rubinstein J, Winaver JM, Knochel JP (1997) Mannitol therapy revisited (1940–1997). Kidney Int 51: 886–894CrossRefGoogle Scholar
  3. 3.
    Brater DC (1994) Diuretic resistance: mechanisms and therapeutic strategies. Cardiology 84 (Suppl 2): 57–67PubMedCrossRefGoogle Scholar
  4. 4.
    Brezis M, Rosen S, Silva P, Epstein FH (1984) Renal ischaemia: A new perspective. Kidney Int 26: 375–383Google Scholar
  5. 5.
    Collins R, Peto R, Mac Mahon S et al.(199o) Blood pressure, stroke and coronary heart disease. Part 2, short-term reductions in blood pressure: Overview of randomized drug trials in their epidemiology context. Lancet 335i827–38Google Scholar
  6. 6.
    Consensus Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 316: 1429–1435CrossRefGoogle Scholar
  7. 7.
    De Wardener HE (199o) The primary role of the kidney and salt intake in the aetiology of essential hypertension: part II. Clinical Science 79 289–297Google Scholar
  8. 8.
    Dikshit K, Vyden JK, Forrester JS, Chatterjee K, Prakash R, Swan HJC (1973) Renal and extra-renal hemodynamic effects of furosemide in congestive heart failure after myocardial infarction. N Engl J Med 288: 1087–1090PubMedCrossRefGoogle Scholar
  9. 9.
    Dorhout Mees EJ, Roos JC, Boer R, Yoe CH, Simatupang TA (1979) Observations on edema formation in the nephrotic syndrome in adults with minimal lesions. Am J Med 67: 378–384 29.Google Scholar
  10. 10.
    Epstein FH (1982) Underfilling versus overflow in hepatic ascites. N Engl J Med 307: 1577–1579 30.Google Scholar
  11. 11.
    Fliser D, Schröter M, Neubeck M, Ritz E (1994) Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure. Kid Int 46: 482–488 31.Google Scholar
  12. 12.
    Gamba G, Miyanoshita A, Lombardi M, Lytton J, Lee WS, Hediger MA, Hebert SC (1994) Molecular cloning, primary structure, and characterization of two members of the mammalian electroneutral sodium-(potassium)-chloride 32. cotransporter family expressed in kidney. J Biol Chem 269: 17713–17722 33.Google Scholar
  13. 13.
    Gerbes AL (1993) Medical treatment of ascites in cirrhosis. Journal of Hepatology 17 (Suppl 2): S4 - S9Google Scholar
  14. 14.
    Green TP, Mirkin BL (1980) Resistance of proteinuric rats to furosemide: Urinary drug protein binding as a determinant of drug effect. Life Sci 26: 623–630Google Scholar
  15. 15.
    Greger RF (1992) Renale Wirkmechanismen der Diuretika. In: Knauf H, Mutschler E (Hrsg) Diuretika. Urban & Schwarzenberg, München, 31–48Google Scholar
  16. 16.
    Greger RF, Heidland A (1997) Action and clinical use of diuretics. In: Cameron S (ed) Oxford Textbook of Clinical Nephrology. Sec Ed Vol 3, Oxford pp 2679–2706Google Scholar
  17. 17.
    Heidbreder E, Hennemann H, Krempien B, Heidland A (1982) Salidiuretische Behandlung der renal-tubulären Azidose und ihrer Komplikationen. Dtsch Med Wochenschr 97: 1504–1507CrossRefGoogle Scholar
  18. 18.
    Heidland A, Hennemann H (1969) Aktivierung des sympathico-adrenalen Systems nach Diuretika - Beziehungen zum salidiuretischen Effekt und Glomerulumfiltrat. Klin Wochenschr 47:5i8–524Google Scholar
  19. 19.
    Heidland A, Wigand ME (1970) Einfluß hoher Furosemiddosen auf die Gehörfunktion bei Urämie. Klin Wochenschr 48: 1052–1056PubMedCrossRefGoogle Scholar
  20. 20.
    Heidland A, Teschner M, Götz R, Heidbreder E (1985) Indikation für höherdosierte Furosemidtherapie - Entwicklung des Therapiekonzeptes und gegenwärtiges Indikationsspektrum. Nieren Hochdruckkrankh 14: 208–216 42.Google Scholar
  21. 21.
    Hoes AW, Grobbee DE, Peet TM and Lubsen J (1994) Do non-potassium sparing diuretics increase the risk of sudden cardiac death in hypertensive patients? Recent evidence. Drugs 47 (5): 711–733PubMedCrossRefGoogle Scholar
  22. 22.
    Holzgreve H (1996) Der Stellenwert von Diuretika als Antihypertensiva. Nieren-und Hochdruckkrankh, Jhrg 25/ No 6: 239–244Google Scholar
  23. 23.
    Kaissling B, Bachmann S, Kriz W (1985) Structural adaptation of the distal convoluted tubule to prolonged furosemide treatment. Am J Physiol 248: F374- F381Google Scholar
  24. 24.
    Knauf H, Mutschler E (1992) Diuretika. Prinzipien der klinischen Anwendung. 2. Aufl. Urban & Schwarzenberg, MünchenGoogle Scholar
  25. 25.
    Knauf H, Mutschler E (1993) Low-dose segmental blockade of the nephron rather than high-dose diuretic monotherapy. Eur J Clin Pharmacol 44 (Suppl I): 63–68CrossRefGoogle Scholar
  26. 26.
    Levinsky NG, Bernhard DB (1988) Mannitol and loop diuretics in acute renal failure. In: Brenner B, Lazarus JM (eds) Acute renal failure, Livingstone, Edinburgh, pp 841–856Google Scholar
  27. 27.
    Lindner A, Cutler RE, Goodman WG (1979) Synergism of dopamine plus furosemide in preventing acute renal failure in the dog. Kidney Int 16: 158–166PubMedCrossRefGoogle Scholar
  28. 28.
    Madkour H, Gadallah M, Riveline B et al. (1995) Comparison between the effects of indapamide and hydrochlorothiazide on creatinine clearance in patients with impaired renal function and hypertension. Am J Nephro115: 251–255Google Scholar
  29. 29.
    Mutschler E (1986) Arzneimittelwirkungen. Wissenschaftliche Verlags-GmbH, StuttgartGoogle Scholar
  30. 30.
    Pollare T, Lithell M, Berne C (1989) A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 321: 868–873PubMedCrossRefGoogle Scholar
  31. 31.
    Rastogi S, Crawford C, Wheeler R, Flanigan W, Arruda JAL (1984) Effect of furosemide on urinary acidificaton in patients with distal renal tubular acidosis. J Lab Clin Med 104: 271–282PubMedGoogle Scholar
  32. 32.
    Ritz E, Stein G, Hartung R (1992) Nebenwirkungen der Diuretika-Therapie. Intensivmedizin 29: 155–161Google Scholar
  33. 33.
    Ritz E, Fliser D, Wiecek A, Matthias S (1994) Pathophysiology and treatment of hypertension and oedema due to renal failure. Cardiology 84 (Suppl 2): 143–154PubMedCrossRefGoogle Scholar
  34. 34.
    Rudy DW, Voelker JR, Green PK, Esparaza FA, Brater DC (1991) Loop diuretics for chronic renal insufficiency: a continuous infusion is more efficacious than bolus therapy. Ann Int Med 115: 360–366PubMedCrossRefGoogle Scholar
  35. 35.
    Sherlock S (1981) Ascites. In: Sherlock S (ed) Diseases of the liver and biliary System. 6th edn, Blackwell Scientific, Oxford, pp 116–133Google Scholar
  36. 36.
    Siscovick DS, Raghunathan TE, Psaty BM et al. (1994) Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 330: 1852–1857PubMedCrossRefGoogle Scholar
  37. 37.
    Sperschneider H, Stein G, Trager A, Keil E (1984) Furosemidwirkungen bei Patienten mit chronischer Niereninsuffizienz. Z Ges Inn Med 39: 261–265PubMedGoogle Scholar
  38. 38.
    Strupp R, Boesken WH, Knauf H (1996) Niedrigdosierte diuretische Kombinationstherapie bei Dialysepatienten. Nieren-and Hochdruckkrankheiten 26 (6): 269–272Google Scholar
  39. 39.
    Suki WN, Yuin JJ, VonMinden M (1970) Acute treatment of hypercalcemia with furosemide. N Engl J Med 283: 836–840PubMedCrossRefGoogle Scholar
  40. 40.
    Tannen R (1985) Diuretic-induced hypokalemia. Kidney Int 28:988 - mooGoogle Scholar
  41. 41.
    Mc Veigh G, Galloway D, Johnston D (1988) The case for low dose diuretics in hypertension: comparison of low and conventional doses of cyclopenthiazide. Br Med J 297: 95–98CrossRefGoogle Scholar
  42. 42.
    Wollam GL, Tarazi RC, Bravo EL, Dustan HP (1982) Diuretic potency of combined hydrochlorothiazide and furosemide therapy in patients with azotemia. Amer J Med 72: 929–938PubMedCrossRefGoogle Scholar
  43. 43.
    Yendt ER, Cohanim M (1978) Prevention of calcium stones with thiazides. Kidney Int 13: 397–409PubMedCrossRefGoogle Scholar
  44. 44.
    Yoshimura A, Ideura T, Isasaki S et al.(1992) Aggravation of minimal change nephrotic synsrome by administration of human albumin. Clin Nephro1 37 (3):109–114Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • A. Heidland
  • U. Bahner

There are no affiliations available

Personalised recommendations